Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis
暂无分享,去创建一个
T. Nishino | H. Yamashita | M. Nishikido | Shuntaro Sato | H. Mukae | Y. Obata | A. Tsujino | M. Kitamura | Kumiko Muta | H. Sakai | Y. Tateishi | Yuki Ota | Tadashi Uramatsu | T. Izumo | T. Matsuo | S. Kitamura | Y. Mochizuki | Takashi Harada | Satoshi Funakoshi
[1] Bernd Weissmuller,et al. Trials , 2020, Israelpolitik.
[2] Shigeru Tanaka,et al. Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] J. Frazão,et al. Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes , 2017, Clinical kidney journal.
[4] T. Nickolas,et al. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] Mary B Leonard,et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.
[6] M. Hayashi,et al. Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator. , 2016, The Keio journal of medicine.
[7] S. Greenberg,et al. Association Between Serum Calcium Level and Extent of Bleeding in Patients With Intracerebral Hemorrhage. , 2016, JAMA neurology.
[8] K. Fujisaki,et al. Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort Study , 2016, Stroke.
[9] Yongjun Cao,et al. Serum Calcium and Phosphate Levels and Short- and Long-Term Outcomes in Acute Intracerebral Hemorrhage Patients. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[10] I. Narita,et al. Higher Mortality Due to Intracerebral Hemorrhage in Dialysis Patients: A Comparison with the General Population in Japan , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[11] K. Iseki,et al. Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study , 2014, PloS one.
[12] M. Landray,et al. Evidence for the Prevention and Treatment of Stroke in Dialysis Patients , 2014, Seminars in dialysis.
[13] M. Sarnak,et al. Ischemic and hemorrhagic stroke: high incidence in hemodialysis and peritoneal dialysis patients. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] Jung-Der Wang,et al. Risk of stroke in long-term dialysis patients compared with the general population. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] Carl-Fredrik Westin,et al. A Novel Approach of Groupwise fMRI-Guided Tractography Allowing to Characterize the Clinical Evolution of Alzheimer's Disease , 2014, PloS one.
[16] A. Matsumura,et al. Clinical outcomes of intracerebral hemorrhage in hemodialysis patients. , 2014, World neurosurgery.
[17] S. Greenberg,et al. Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. , 2013, JAMA neurology.
[18] K. Toyoda,et al. Low Serum Calcium Levels Contribute to Larger Hematoma Volume in Acute Intracerebral Hemorrhage , 2013, Stroke.
[19] N. Fujii,et al. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[20] N. Duncan,et al. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] D. Spiegel,et al. Calcium balance in normal individuals and in patients with chronic kidney disease on low and high calcium diets , 2012, Kidney international.
[22] T. Drüeke,et al. Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part). , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] A. Macleod,et al. Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .
[24] M. Alberts,et al. Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage , 2009, Stroke.
[25] P. Kerr,et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] S. Ibayashi,et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] T. Davis,et al. Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke , 2002, Stroke.
[28] J. De Keyser,et al. Use of the Barthel index and modified Rankin scale in acute stroke trials. , 1999, Stroke.
[29] J. Marín,et al. Mechanisms involved in the cellular calcium homeostasis in vascular smooth muscle: calcium pumps. , 1998, Life sciences.
[30] P. Whelton,et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.
[31] Y. Yamamoto,et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] K. Iseki,et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. , 1993, Kidney international.
[33] J. Broderick,et al. Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.
[34] G. Boysen,et al. Prognosis for Patients Treated Conservatively for Spontaneous Intracerebral Hematomas , 1984, Stroke.
[35] Eisenberg,et al. Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins , 1973, British medical journal.
[36] W. C. O'Neill,et al. Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high? , 2016, Kidney international.
[37] Supplemental Tables,et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.
[38] M. Fukagawa,et al. Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). , 2008, Internal medicine.
[39] J. Kyriazis,et al. Dialysate calcium profiling during hemodialysis: use and clinical implications. , 2002, Kidney international.